Melanoma is the most dangerous form of skin cancer and the leading cause of deaths due to skin disease. In a new study examining the life expectancy of melanoma patients, researchers found that a particular treatment option called ipilimumab was highly effective. According to the longest, follow-up study, melanoma patients that used ipilimumab can survive up to 10 years.
Events
Translational Cancer Research Conference
On behalf of the Hunter Medical Research Institute (HMRI) Cancer Research Program (now called Hunter Cancer Research Alliance), you are warmly like to invite you to attend the 2013 Translational…
Read More Are you interested in teaching our future doctors?
The Patient Teaching Association (PTA) program is managed by the Eastern Health Clinical School, part of the Monash University Medical School located at Eastern Health. Medical students having their clinical…
Read More MASC Annual Scientific and General Meeting 2013
MASC Annual Scientific and General Meeting will be held in association with the Global Controversies and Advances in Skin Cancer Conference. When: Wednesday 20th November 2013 Where: Brisbane Convention Centre, Brisbane
Read More